Works matching IS 03065251 AND DT 2017 AND VI 83 AND IP 2

Results: 25

Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 269, doi. 10.1111/bcp.13095

By:

Talavera Pons, Sarah;
Boyer, Anne;
Lamblin, Geraldine;
Chennell, Philip;
Châtenet, François‐Thibault;
Nicolas, Carine;
Sautou, Valérie;
Abergel, Armand

Publication type:

Article

Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 400, doi. 10.1111/bcp.13096

By:

Ramírez, Elena;
Medrano‐Casique, Nicolás;
Tong, Hoi Y.;
Bellón, Teresa;
Cabañas, Rosario;
Fiandor, Ana;
González‐Ramos, Jessica;
Herranz, Pedro;
Trigo, Elena;
Muñoz, Mario;
Borobia, Alberto M.;
Carcas, Antonio J.;
Frías, Jesús

Publication type:

Article

Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 370, doi. 10.1111/bcp.13097

By:

Williams, Daphne;
Tao, Xiaolu;
Zhu, Lili;
Stonier, Michele;
Lutz, Justin D.;
Masson, Eric;
Zhang, Sean;
Ganguly, Bishu;
Tzogas, Zoe;
Lubin, Susan;
Murthy, Bindu

Publication type:

Article

The value of patient reporting to the pharmacovigilance system: a systematic review.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 227, doi. 10.1111/bcp.13098

By:

Inácio, Pedro;
Cavaco, Afonso;
Airaksinen, Marja

Publication type:

Article

An assessment of the variation in the concentration of acetylcysteine in infusions for the treatment of paracetamol overdose.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 393, doi. 10.1111/bcp.13099

By:

Bailey, George P.;
Wood, David M.;
Archer, John R. H.;
Rab, Edmund;
Flanagan, Robert J.;
Dargan, Paul I.

Publication type:

Article

Chemical gastritis and colitis related to hydrogen peroxide mouthwash.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 427, doi. 10.1111/bcp.13100

By:

Zanelli, Magda;
Ragazzi, Moira;
De Marco, Loredana

Publication type:

Article

Population pharmacokinetics and analgesic potency of oxycodone.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 314, doi. 10.1111/bcp.13101

By:

Choi, Byung‐Moon;
Lee, Yong‐Hun;
An, Sang‐Mee;
Lee, Soo‐Han;
Lee, Eun‐Kyung;
Noh, Gyu‐Jeong

Publication type:

Article

An S-warfarin and AZD1981 interaction: in vitro and clinical pilot data suggest the N-deacetylated amino acid metabolite as the primary perpetrator.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 381, doi. 10.1111/bcp.13102

By:

Grime, Ken;
Pehrson, Rikard;
Nordell, Pär;
Gillen, Michael;
Kühn, Wolfgang;
Mant, Timothy;
Brännström, Marie;
Svanberg, Petter;
Jones, Barry;
Brealey, Clive

Publication type:

Article

Poor reporting and documentation in drug-associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis - Lessons for medication safety.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 224, doi. 10.1111/bcp.13103

By:

Goldblatt, Caitlin;
Khumra, Sharmila;
Booth, Jane;
Urbancic, Karen;
Grayson, M. Lindsay;
Trubiano, Jason A.

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 217, doi. 10.1111/bcp.13106
Publication type:: Article

Contraindicated use of 5-alpha-reductase inhibitors in women.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 429, doi. 10.1111/bcp.13118

By:

Teichert, Martina;
Puijenbroek, Eugene;
Stricker, Bruno H.

Publication type:

Article

Understanding and applying pharmacometric modelling and simulation in clinical practice and research.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 247, doi. 10.1111/bcp.13119

By:

Standing, Joseph F.

Publication type:

Article

Altered pharmacodynamics and pharmacokinetics of cisatracurium in patients with severe mitral valve regurgitation during anaesthetic induction period.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 363, doi. 10.1111/bcp.13121

By:

Liu, Jiayi;
Lu, Chunying;
Zou, Qirong;
Wang, Sheng;
Peng, Xuemei

Publication type:

Article

Endpoints in strategies to reduce polypharmacy.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 432, doi. 10.1111/bcp.13122

By:

Gaviria‐Mendoza, Andrés;
Machado‐Alba, Jorge Enrique;
Castaño‐Montoya, Juan Pablo;
Machado‐Duque, Manuel Enrique;
Giraldo‐Giraldo, Claudia

Publication type:

Article

Translating QT interval prolongation from conscious dogs to humans.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 349, doi. 10.1111/bcp.13123

By:

Dubois, Vincent F. S.;
Smania, Giovanni;
Yu, Huixin;
Graf, Ramona;
Chain, Anne S. Y.;
Danhof, Meindert;
Della Pasqua, Oscar

Publication type:

Article

The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 416, doi. 10.1111/bcp.13124

By:

Walter, Scott R.;
Day, Richard O.;
Gallego, Blanca;
Westbrook, Johanna I.

Publication type:

Article

Reply to 'Endpoints in strategies to reduce polypharmacy'.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 434, doi. 10.1111/bcp.13125

By:

Johansson, Tim;
Flamm, Maria;
Sönnichsen, Andreas

Publication type:

Article

Microtubule destabilising agents: far more than just antimitotic anticancer drugs.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 255, doi. 10.1111/bcp.13126

By:

Bates, Darcy;
Eastman, Alan

Publication type:

Article

Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 326, doi. 10.1111/bcp.13127

By:

Denney, William S.;
Sonnenberg, Gabriele E.;
Carvajal‐Gonzalez, Santos;
Tuthill, Theresa;
Jackson, V. Margaret

Publication type:

Article

Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 339, doi. 10.1111/bcp.13128

By:

Täubel, Jörg;
Ferber, Georg;
Fox, Gabriel;
Fernandes, Sara;
Lorch, Ulrike;
Camm, A. John

Publication type:

Article

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 294, doi. 10.1111/bcp.13129

By:

Kuip, Evelien J. M.;
Zandvliet, Maarten L.;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.;
Rijt, Carin C. D.

Publication type:

Article

Composite endpoints and the distortion of risk-benefit analysis.

Published in:

2017

By:

Warren, John B.

Publication type:

Editorial

Discrepancies in paper by Chiam et al.: The haemodynamic effects of intravenous paracetamol.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 435, doi. 10.1111/bcp.13182

By:

Westergren, Tone;
Debernard, Karen Astrid Boldingh

Publication type:

Article

Erratum.

Published in:: British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 436, doi. 10.1111/bcp.13187
Publication type:: Article

Issue highlights.

Published in:: 2017
Publication type:: Other